or
forgot password
  • cancer clinical trials in bismarck, ND

  • Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    St. Alexius Medical Center Cancer Center
    Bismarck, North Dakota 58502
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Mid Dakota Clinic, PC

    Trial Locations
    Mid Dakota Clinic, PC
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Brain and Central Nervous System Tumors
    Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
    St. Alexius Medical Center Cancer Center
    Bismarck, North Dakota 58502
    Brain and Central Nervous System Tumors
    Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
    Bismarck Cancer Center

    Trial Locations
    Bismarck Cancer Center
    Mid Dakota Clinic, PC
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Anal Cancer, Carcinoma of the Appendix, Colorectal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Liver Cancer, Nausea and Vomiting, Pancreatic Cancer, Primary Peritoneal Cavity Cancer, Small Intestine Cancer
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Medcenter One Hospital Cancer Care Center

    Trial Locations
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Lung Cancer
    Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
    St. Alexius Medical Center Cancer Center
    Bismarck, North Dakota 58502
    Carcinoma of Unknown Primary
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Bismarck Cancer Center

    Trial Locations
    Bismarck Cancer Center
    Mid Dakota Clinic
    Saint Alexius Medical Center
    Sanford Bismarck Medical Center
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Medcenter One Hospital Cancer Care Center

    Trial Locations
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Lung Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Medcenter One Hospital Cancer Care Center

    Trial Locations
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Melanoma (Skin)
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Medcenter One Hospital Cancer Care Center

    Trial Locations
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Study of Tissue and Blood Samples From Patients With High-Grade Glioma
    Bismarck Cancer Center

    Trial Locations
    Bismarck Cancer Center
    Mid Dakota Clinic, PC
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Brain and Central Nervous System Tumors
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Medcenter One Hospital Cancer Care Center

    Trial Locations
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Colorectal Cancer, Precancerous Condition
    Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
    St. Alexius Medical Center Cancer Center
    Bismarck, North Dakota 58502
    Leukemia
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Bismarck Cancer Center

    Trial Locations
    Bismarck Cancer Center
    Mid Dakota Clinic
    Saint Alexius Medical Center
    Sanford Bismarck Medical Center
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    St. Alexius Medical Center Cancer Center
    Bismarck, North Dakota 58502
    Lung Cancer
    Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
    Legacy Pharma Research
    Bismarck, North Dakota 58501
    Multiple Myeloma
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Mid Dakota Clinic, PC

    Trial Locations
    Mid Dakota Clinic, PC
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Lung Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    Med Center One
    Bismarck, North Dakota 58501
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Bismarck Cancer Center

    Trial Locations
    Bismarck Cancer Center
    Mid Dakota Clinic
    Saint Alexius Medical Center
    Sanford Bismarck Medical Center
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    Bismarck Cancer Center

    Trial Locations
    Bismarck Cancer Center
    Mid Dakota Clinic, PC
    Medcenter One Hospital Cancer Care Center
    St. Alexius Medical Center Cancer Center
    Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Medcenter One Hospital Cancer Care Center
    Bismarck, North Dakota 58501
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity